title: Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma.
abstract: The regulatory mechanisms underlying the overexpression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in highly invasive breast carcinomas remain poorly understood. In this study, we have simultaneously determined the level of uPAR and the activity of the transcription factor Sp1 in 14 breast carcinomas and 5 benign lesions. We found that uPAR levels and Sp1-binding activity are coordinately elevated in malignant tumors (r, 0.94; P < 0.001). On the contrary, undetectable or only barely detectable levels of uPAR and Sp1 activity were found in benign breast lesions. Finally, the engagement of uPAR by catalytically inactive uPA in the MDA-MB-231 breast carcinoma cell line results in a rapid up-regulation of Sp1-binding activity followed by an increase of uPAR protein. These results, taken together, suggest the existence of a uPA-dependent positive regulatory loop that may progressively enhance malignant breast cell invasiveness.
authors.affiliation: Centro Medicina Nucleare, Consiglio Nazionale delle Ricerche, Dipartimento di Scienze Biomorfologiche e Funzionali, Università Federico II, Naples, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Zannetti
authors.forename: S
authors.initials: S
authors.lastname: Del Vecchio
authors.forename: M V
authors.initials: MV
authors.lastname: Carriero
authors.forename: R
authors.initials: R
authors.lastname: Fonti
authors.forename: P
authors.initials: P
authors.lastname: Franco
authors.forename: G
authors.initials: G
authors.lastname: Botti
authors.forename: G
authors.initials: G
authors.lastname: D'Aiuto
authors.forename: M P
authors.initials: MP
authors.lastname: Stoppelli
authors.forename: M
authors.initials: M
authors.lastname: Salvatore
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015153:Blotting, Western; D001940:Breast / Q000737:chemistry / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D004268:DNA-Binding Proteins / Q000378:metabolism; D005260:Female; D006367:HeLa Cells; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009841:Oligonucleotides / Q000378:metabolism; D011485:Protein Binding; D011956:Receptors, Cell Surface / Q000096:biosynthesis*; D055293:Receptors, Urokinase Plasminogen Activator; D016329:Sp1 Transcription Factor / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
chemical_list: D004268:DNA-Binding Proteins; D009841:Oligonucleotides; C524898:PLAUR protein, human; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D016329:Sp1 Transcription Factor; D014568:Urokinase-Type Plasminogen Activator